DEA Administrator Terrance Cole
DEA News:
WASHINGTON, D.C. — The U.S. Drug Enforcement Administration filed its intent July 1 to temporarily place 7-hydroxymitagynine (7-OH) and three related substances into Schedule I of the Controlled Substances Act (CSA). Prior to DEA issuing this notice, the Department of Health and Human Services (HHS) confirmed synthetic 7-OH, and the three related substances have no accepted medical use and a high potential for abuse.
Two Notices of Intent (NOI) were sent to the Federal Register on Wednesday, July 1, 2026. One NOI addresses 7-OH above a specified Read More







NFIB News:
Health Cabinet Secretary Kari Armijo

DAV News:

ALTSD News: